A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

16 May 2019

New study from the Foundation analyses 10 years of data on pharma companies and access to medicine

Amsterdam, the Netherlands, 16 May 2019 – In a new report published today, the Access to Medicine Foundation shows where pharmaceutical companies have...

29 Nov 2018

2018 Access to Medicine Index finds that pharmaceutical companies are deepening their focus on Africa

Amsterdam, the Netherlands, 29 November 2018 – The new Access to Medicine Index notes increasing interest from multinational pharmaceutical companies...

20 Nov 2018

Now online: 6th Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the po...

20 Nov 2018

Coming up: Index briefings to inform policy on global health

The Access to Medicine Foundation will be holding a series of policy and technical briefings with government representatives from Germany, Japan...

20 Nov 2018

New online: you choose which companies to compare side by side

We are publishing the new Access to Medicine Index on a new website. Our goal was to make it easier for you to find what you are looking for and to co...

05 Nov 2018

Goldman Sachs & UBS to co-host investor launches of 2018 Access to Medicine Index

On Thursday 22 November, Goldman Sachs will co-host the London investor event about the 2018 Index together with the Access to Medicine Foundation. Tw...

22 Oct 2018

2018 Access to Medicine Index launches on 20 November

The Access to Medicine Foundation will publish the 6th Access to Medicine Index on Tuesday 20 November 2018. The latest report will show what 20 of th...

03 Aug 2018

New paper explains expanded Index focus on global health R&D

A new article published in Health Research Policy and Systems sets out how the 2018 Access to Medicine Index will analyse pharmaceutical companies R&D...

02 Aug 2018

Data analysis gathers pace for 2018 Access to Medicine Index

The 2018 Access to Medicine Index will be the 6th ranking of the world’s largest pharmaceutical companies on their access-to-medicine performances. We...

13 Jul 2018

Index added to new online toolbox for impact investors

The Access to Medicine Index and AMR Benchmark have been added to Navigating Impact, a new online resource centre developed specifically for impact in...

21 Feb 2018

New IP-sharing framework to accelerate R&D

The Access to Medicine Foundation has worked with BIO Ventures for Global Health (BVGH) to develop a framework for identifying which IP assets are mos...

25 Jan 2018

Live WEF discussion with Bill Gates & Jayasree Iyer at 1pm CET: “New Era For Global Health”

Jayasree K. Iyer joins Bill Gates and others to discuss how new leadership, policy and business models are rewriting the global health playbook.

04 Jan 2018

Why the Index is now researching access to cancer care

For the first time, in 2018, the Access to Medicine Index is looking at cancer. Writing in Cancer Control 2017, we describe why and how it has been br...

13 Dec 2017

How the Access to Medicine Foundation is raising the bar for Index making

The Foundation’s sixth Index cycle is proving to be its most innovative – this article provides a brief rundown of the groundwork laid for the next Ac...

05 Oct 2017

Latest framework for action by pharmaceutical companies on access to medicine

The world’s leading pharmaceutical companies have the power and the products to improve access to medicine. To help guide their actions, the Access to...

22 May 2017

New study finds wide variety in pharma companies’ cancer access programmes

Today, the Access to Medicine Foundation publishes the first analysis of pharmaceutical company actions to improve cancer care in the developing world...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.